In view of the manifold increase in cases of dengue and chikungunya in the country, the Committee on Health and Family Welfare stressed that the role of ICMR is of prime importance in researching and developing new medicines for the cure of such diseases.
"It has also come to the notice of the Committee through recent media reports that some pharma companies have collaborated for development of dengue vaccine, targeted against all four serotypes of dengue virus.
"Since the whole process of developing drugs and then clinically testing them entails a lot of time, efforts should be made by ICMR to do focussed research for funding cure for vector-borne diseases," the Committee recommended.
The Committee further observed that in view of the dynamic inter-national health research environment and the current and future health challenges, the role of ICMR is very crucial and if its projects are plagued with under-funding, it can have very serious repercussion and undermine the desired outcomes in the health sector.
Noting that out of Rs 80 lakh, only Rs 39 lakh has been utilised, the Committee said that such instances of under-utilisation of funds reflect lack of efficiency of the administrative machinery and planning.
"The Committee would expect the Department to devise an effective mechanism for ensuring optimum and judicious utilisation of allocated funds for 2016-17 under this head," it said.
Disclaimer: No Business Standard Journalist was involved in creation of this content